Adenosine A2A Receptor Agonists Promote More Rapid Wound Healing Than Recombinant Human Platelet–Derived Growth Factor (Becaplermin Gel)

[1]  GB Köveker.  GROWTH FACTORS IN CLINICAL PRACTICE , 2000, International journal of clinical practice.

[2]  Köveker Gb,et al.  GROWTH FACTORS IN CLINICAL PRACTICE , 2000, International journal of clinical practice.

[3]  K. Klotz.  Adenosine receptors and their ligands , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  G. Sibbald,et al.  Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  T. K. Hunt,et al.  Physiology of wound healing. , 2000, Advances in skin & wound care.

[6]  P. Rhee,et al.  Cyclopentyladenosine improves cell proliferation, wound healing, and hair growth. , 1999, The Journal of surgical research.

[7]  K. Moore.  Cell biology of chronic wounds: the role of inflammation. , 1999, Journal of wound care.

[8]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[9]  G R Tobin,et al.  Physiology and healing dynamics of chronic cutaneous wounds. , 1998, American journal of surgery.

[10]  T. K. Hunt,et al.  The future of recombinant growth factors in wound healing. , 1998, American journal of surgery.

[11]  E. LeGrand.  Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. , 1998, American journal of surgery.

[12]  Spiegler,et al.  Adenine nucleotides modulate epithelial wound healing in vitro , 1998, European journal of clinical investigation.

[13]  R. Quinn,et al.  Adenosine receptors: new opportunities for future drugs. , 1998, Bioorganic & medicinal chemistry.

[14]  D. S. Mcleod,et al.  Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. , 1998, Current eye research.

[15]  B. Cronstein,et al.  Wound Healing Is Accelerated by Agonists of Adenosine A2 (Gα s-linked) Receptors , 1997, The Journal of experimental medicine.

[16]  W. Meyer-Ingold,et al.  Platelet‐derived growth factor. , 1995, Cell biology international.

[17]  S. Baumgartner-Parzer,et al.  Stimulation of human umbilical vein endothelial cell proliferation by A2‐adenosine and β2‐adrenoceptors , 1995, British journal of pharmacology.

[18]  R. Allman,et al.  Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. , 1994, The American journal of pathology.

[19]  H. Steenfos,et al.  Growth factors and wound healing. , 1994, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[20]  S. Hourani,et al.  Adenosine receptor subtypes. , 1993, Trends in pharmacological sciences.

[21]  R. Kirsner,et al.  The wound healing process. , 1993, Dermatologic clinics.

[22]  R. Clark.  Biology of dermal wound repair. , 1993, Dermatologic clinics.

[23]  M. F. Ethier,et al.  Adenosine stimulates proliferation of human endothelial cells in culture. , 1993, The American journal of physiology.

[24]  S. Kartha,et al.  Adenine nucleotides stimulate migration in wounded cultures of kidney epithelial cells. , 1992, The Journal of clinical investigation.

[25]  H. Granger,et al.  Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. , 1988, The American journal of physiology.

[26]  J. Linden.  Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[27]  B. Cronstein,et al.  Role of P1 Receptors in Inflammation , 2001 .

[28]  D. S. Mcleod,et al.  Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy. , 2000, Investigative ophthalmology & visual science.

[29]  A. Graham.  The use of growth factors in clinical practice. , 1998, Journal of Wound Care.

[30]  L. Arroyo,et al.  2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. , 1991, Journal of Medicinal Chemistry.